Regulating Compounding Pharmacies: Why An Increased FDA Role Shouldn’t Be Our Default Option
By Patrick O’Leary A friend and I were having a conversation about health policy the other day when he observed that drug regulators like FDA face an impossible task in terms of public expectations: as consumers, we expect the drugs we take to be 100% safe, 100% of the time. Of course, no regulator, no…